ZA200610121B - Substituted diketopiperazines as oxytocin antagonists - Google Patents

Substituted diketopiperazines as oxytocin antagonists

Info

Publication number
ZA200610121B
ZA200610121B ZA200610121A ZA200610121A ZA200610121B ZA 200610121 B ZA200610121 B ZA 200610121B ZA 200610121 A ZA200610121 A ZA 200610121A ZA 200610121 A ZA200610121 A ZA 200610121A ZA 200610121 B ZA200610121 B ZA 200610121B
Authority
ZA
South Africa
Prior art keywords
oxytocin antagonists
substituted diketopiperazines
diketopiperazines
substituted
oxytocin
Prior art date
Application number
ZA200610121A
Other languages
English (en)
Inventor
Borthwick Alan David
Sollis Steven Leslie
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA200610121B publication Critical patent/ZA200610121B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200610121A 2004-06-23 2006-12-04 Substituted diketopiperazines as oxytocin antagonists ZA200610121B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0414092.7A GB0414092D0 (en) 2004-06-23 2004-06-23 Novel compounds

Publications (1)

Publication Number Publication Date
ZA200610121B true ZA200610121B (en) 2008-08-27

Family

ID=32800052

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200610121A ZA200610121B (en) 2004-06-23 2006-12-04 Substituted diketopiperazines as oxytocin antagonists

Country Status (18)

Country Link
US (1) US20070208031A1 (pt)
EP (1) EP1758893A1 (pt)
JP (1) JP2008503535A (pt)
CN (1) CN1989130A (pt)
AR (1) AR049651A1 (pt)
AU (1) AU2005256471A1 (pt)
BR (1) BRPI0512359A (pt)
CA (1) CA2571529A1 (pt)
GB (1) GB0414092D0 (pt)
IL (1) IL179912A0 (pt)
MA (1) MA28698B1 (pt)
MX (1) MXPA06014544A (pt)
NO (1) NO20070157L (pt)
PE (1) PE20060533A1 (pt)
RU (1) RU2007102272A (pt)
TW (1) TW200616635A (pt)
WO (1) WO2006000400A1 (pt)
ZA (1) ZA200610121B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2641806B1 (fr) * 1989-01-16 1992-05-07 Diffusion Rech Tech Financ Procede de stabilisation d'une aire de terrain meuble
GB0130677D0 (en) * 2001-12-21 2002-02-06 Glaxo Group Ltd Medicaments and novel compounds
GB0314738D0 (en) * 2003-06-24 2003-07-30 Glaxo Group Ltd Novel compounds
GB0414100D0 (en) * 2004-06-23 2004-07-28 Glaxo Group Ltd Novel compounds
GB0414093D0 (en) 2004-06-23 2004-07-28 Glaxo Group Ltd Novel compounds
EP2184987A4 (en) * 2007-07-31 2011-09-28 Burnham Inst Medical Research BIDENTATE COMPOUNDS AS KINASE INHIBITORS
US20100038143A1 (en) * 2008-08-14 2010-02-18 George Alexander Burnett Drill cuttings treatment systems
US8716286B2 (en) 2009-10-30 2014-05-06 Glaxo Group Limited Crystalline forms of (3R, 6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethyl-3-pyridinyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione
CN109305969B (zh) * 2017-07-27 2023-03-10 江苏恒瑞医药股份有限公司 哌嗪-2,5-二酮类衍生物、其制备方法及其在医药上的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130677D0 (en) * 2001-12-21 2002-02-06 Glaxo Group Ltd Medicaments and novel compounds
GB0414100D0 (en) * 2004-06-23 2004-07-28 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
PE20060533A1 (es) 2006-09-03
AU2005256471A1 (en) 2006-01-05
MA28698B1 (fr) 2007-06-01
BRPI0512359A (pt) 2008-03-04
MXPA06014544A (es) 2007-03-12
IL179912A0 (en) 2007-05-15
US20070208031A1 (en) 2007-09-06
CA2571529A1 (en) 2006-01-05
RU2007102272A (ru) 2008-07-27
WO2006000400A1 (en) 2006-01-05
JP2008503535A (ja) 2008-02-07
AR049651A1 (es) 2006-08-23
EP1758893A1 (en) 2007-03-07
CN1989130A (zh) 2007-06-27
TW200616635A (en) 2006-06-01
GB0414092D0 (en) 2004-07-28
NO20070157L (no) 2007-01-23

Similar Documents

Publication Publication Date Title
HK1113927A1 (en) Substituted triazole derivatives as oxytocin antagonists
HK1112457A1 (en) Substituted piperazines as cb1 antagonists
EP1940412A4 (en) NEW OPIOID ANTAGONISTS
IL237513A0 (en) Piperazindiones as oxytocin receptor antagonists
ZA200803811B (en) Neuropolin antagonists
IL182828A0 (en) Constrained compounds as cgrp-receptor antagonists
IL208963A0 (en) Substituted quinoline compounds
PL1963369T3 (pl) Antagoniści IL-21
GB0404124D0 (en) Antagonists of GIP
IL180587A0 (en) Heterocyclic compounds
HK1095822A1 (en) Triazole derivatives as vasopressin antagonists
EP1758458A4 (en) COMPOSITIONS CONTAINING OPIOIDANT AGONISTS
IL179912A0 (en) Substituted diketopiperazines as oxytocin antagonists
EG24929A (en) Substituted diketopiperazines and their use as oxytocin antagonists
IL179888A0 (en) Compounds as ccr5 antagonists
IL183647A (en) The heterocyclic compounds are converted into 3-ethylidenehydrazino
IL187410A0 (en) Quinoline derivatives as nk3 antagonists
ZA200700162B (en) Novel heterocyclic compounds
ZA200802339B (en) Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
GB0427403D0 (en) Novel compounds I
IL179789A0 (en) Substituted benzoylcyclohexandiones as herbicides
ZA200605575B (en) Substituted quinoline compounds
ZA200703525B (en) Constrained compounds as CGRP-receptor antagonists
GB0415110D0 (en) Substituted triazole derivatives as oxytocin antagonists
GB0425729D0 (en) Heterocyclic compounds